Literature DB >> 12218600

Rhinocerebral mucormycosis in a boy with recurrent acute lymphoblastic leukemia: long-term survival with systemic antifungal treatment.

Goetz Wehl1, Wolfgang Hoegler, Gabriele Kropshofer, Bernhard Meister, Franz-Martin Fink, Andreas Heitger.   

Abstract

Rhinocerebral mucormycosis is rare in hematologic malignancies and usually leads to death within weeks. In contrast, chronic rhinocerebral mucormycosis takes a slowly progressive course and has not been reported in hematologic malignancies in children so far. The authors report the long-term survival of a boy with rhinocerebral mucormycosis in a relapse of acute lymphoblastic leukemia after allogeneic cord blood transplantation. The disease started acutely but took a chronic course thereafter. No surgical debridement was performed because of extensive involvement of the sinuses, orbits, and cerebrum. His long-term survival of 15 months is attributed to the long-range administration of liposomal amphotericin B, early neutrophil recovery, and slow progression of the relapsing acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218600     DOI: 10.1097/00043426-200208000-00017

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Aggressive Combined Medical and Surgical Management of Mucormycosis Results in Disease Eradication in 2 Pediatric Patients.

Authors:  Haley F M Augustine; Colin White; James Bain
Journal:  Plast Surg (Oakv)       Date:  2017-06-28       Impact factor: 0.947

2.  Recurrent Rhino-Ocular-Cerebral Mucormycosis in a Leukemic Child: A Case Report and Review of Pediatric Literature.

Authors:  Francesco De Leonardis; Teresa Perillo; Giuseppe Giudice; Gianfranco Favia; Nicola Santoro
Journal:  Pediatr Rep       Date:  2015-09-28

Review 3.  Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literature.

Authors:  Annalisa di Coste; Francesco Costantino; Luigi Tarani; Vincenzo Savastano; Claudio Di Biasi; Laura Schiavi; Ilaria Ernesti; Taulant Melengu; Marzia Duse
Journal:  Ital J Pediatr       Date:  2013-12-10       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.